Page last updated: 2024-09-04

tecadenoson and Tachycardia, Paroxysmal

tecadenoson has been researched along with Tachycardia, Paroxysmal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bahnson, T; Belardinelli, L; Bloomfield, DM; Curtis, AB; Dhala, A; Ellenbogen, K; Fogel, RI; Gold, M; Gonzalez, MD; Kadish, A; Niazi, I; Prystowsky, EN; Shreeniwas, R; Wilber, DJ; Wolff, AA	1

Trials

1 trial(s) available for tecadenoson and Tachycardia, Paroxysmal

Article	Year
Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonist. Journal of the American College of Cardiology, 2003, Sep-17, Volume: 42, Issue:6 Topics: Adenosine; Adult; Aged; Aged, 80 and over; Female; Furans; Humans; Male; Middle Aged; Purinergic P1 Receptor Agonists; Remission Induction; Tachycardia, Paroxysmal; Tachycardia, Supraventricular	2003

Article

Year

Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonist.

Journal of the American College of Cardiology, 2003, Sep-17, Volume: 42, Issue:6

Topics: Adenosine; Adult; Aged; Aged, 80 and over; Female; Furans; Humans; Male; Middle Aged; Purinergic P1 Receptor Agonists; Remission Induction; Tachycardia, Paroxysmal; Tachycardia, Supraventricular

2003